| Literature DB >> 33666708 |
Ezgi Eyluel Bankoglu1, Franzisca Stipp1, Johanna Gerber1, Florian Seyfried2, August Heidland3, Udo Bahner3, Helga Stopper4.
Abstract
The comet assay is a commonly used method to determine DNA damage and repair activity in many types of samples. In recent years, the use of the comet assay in human biomonitoring became highly attractive due to its various modified versions, which may be useful to determine individual susceptibility in blood samples. However, in human biomonitoring studies, working with large sample numbers that are acquired over an extended time period requires some additional considerations. One of the most important issues is the storage of samples and its effect on the outcome of the comet assay. Another important question is the suitability of different blood preparations. In this study, we analysed the effect of cryopreservation on DNA damage and repair activity in human blood samples. In addition, we investigated the suitability of different blood preparations. The alkaline and FPG as well as two different types of repair comet assay and an in vitro hydrogen peroxide challenge were applied. Our results confirmed that cryopreserved blood preparations are suitable for investigating DNA damage in the alkaline and FPG comet assay in whole blood, buffy coat and PBMCs. Ex vivo hydrogen peroxide challenge yielded its optimal effect in isolated PBMCs. The utilised repair comet assay with either UVC or hydrogen peroxide-induced lesions and an aphidicolin block worked well in fresh PBMCs. Cryopreserved PBMCs could not be used immediately after thawing. However, a 16-h recovery with or without mitotic stimulation enabled the application of the repair comet assay, albeit only in a surviving cell fraction.Entities:
Keywords: Blood samples; Comet assay; DNA damage; DNA repair; Human biomonitoring
Mesh:
Substances:
Year: 2021 PMID: 33666708 PMCID: PMC8113209 DOI: 10.1007/s00204-021-03012-4
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 5.153
The percentage of DNA in tail from methodological negative and positive control
| DNA in tail (%) (Mean ± SD, | Significance | |
|---|---|---|
| 1% DMSO | 4.92 ± 1.37 | |
| 100 µM MMS | 8.18 ± 1.35 | * |
| 1% Water | 5.31 ± 0.72 (Buffer control) 9.43 ± 1.93 (FPG enzyme) | |
| 2 mM KBrO3 | 4.82 ± 0.62 (Buffer control) 23.19 ± 8.41 (FPG enzyme) | * |
Fig. 1A comparison on basal level of DNA damage in three different blood preparations and the effect of cryopreservation on DNA damage. a Basal level of DNA damage among three different blood preparations in alkaline comet (n = 20) and FPG comet assay (n = 20 for whole blood and buffy coat, n = 10 for PBMCs) as well as after an ex vivo hydrogen peroxide challenge (n = 10 for whole blood and buffy coat, n = 20 for PBMCs). Basal DNA strand breaks: *p ≤ 0.05 vs. whole blood, ● p ≤ 0.05 vs. buffy coat and ■ p ≤ 0.05 vs. PBMCs. Ex vivo H2O2 challenge: ♦ p ≤ 0.05 vs. whole blood and □p ≤ 0.05 vs. buffy coat. b The effect of cryopreservation on basal level of DNA strand breaks in three different blood preparations (n = 20). Fresh: *p ≤ 0.05 vs. whole blood and ● p ≤ 0.05 vs. buffy coat. Cryopreserved: ◦p ≤ 0.05 vs. PBMCs. c The effect of cryopreservation on basal level of DNA oxidation damage in three different blood preparations (n = 20 for whole blood and buffy coat, n = 10 for PBMCs). Buffer (for fresh and cryopreserved): *p ≤ 0.05 vs. whole blood, ● p ≤ 0.05 vs. buffy coat and ■ p ≤ 0.05 vs. PBMCs. Cryopreserved (only for Buffer): ◦p ≤ 0.05 vs. PBMCs. d The effect of cryopreservation on hydrogen peroxide-induced DNA strand breaks in PBMCs (n = 20). ◦p ≤ 0.05 vs. Buffer-fresh, ● p ≤ 0.05 vs. Buffer-cyropreserved and ★ p ≤ 0.05 vs. FPG-fresh
Fig. 2The results of aphidicolin block base excision repair (BER) comet assay. a BER activity in freshly isolated PBMCs (n = 20). b BER activity in cryopreserved PBMCs (n = 20). c BER activity in cryopreserved PBMCs after 16 h recovery (n = 6). d BER activity in cryopreserved PBMCs after 16 h PHA stimulation (n = 6). t0: directly after treating and t1: an hour repair. ● p ≤ 0.05 vs. Controlt0, ◦p ≤ 0.05 vs. Control t1, * p ≤ 0.05 vs. 40 µM H2O2 t0, p ≤ 0.05 vs. 40 µM H2O2 + APC t0, □ p ≤ 0.05 vs. Control + APC t0, ■ p ≤ 0.05 vs. Control + APC t1, ∆ p ≤ 0.05 vs. Control t0 and ♦ p ≤ 0.05 vs. Control + APC t0
Fig. 3The results of aphidicolin block nucleotide excision (NER) repair comet assay. a NER activity in freshly isolated PBMCs (n = 20). b NER activity in cryopreserved PBMCs (n = 20). c NER activity in cryopreserved PBMCs after 16 h recovery (n = 6). d NER activity in crypreserved PBMCs after 16 h PHA stimulation (n = 6). t0: directly after treating and t2: 2 h repair. ◦p ≤ 0.05 vs. Control + APCt2, * p ≤ 0.05 vs. 5 J/m2 UVC t0, p ≤ 0.05 vs. 5 J/m2 UVC + APC t0, ■ p ≤ 0.05 vs. Control + APC t2, ∆ p ≤ 0.05 vs. Control t0 and ♦ p ≤ 0.05 vs. Control + APC t0
The percentage of vital cells and reduction in the number of PBMCs after thawing directly, after 16 h recovery and after 16 h PHA stimulation
| Vital cells (%) (Mean ± SD, | Reduction in the number of PBMCs (%) | |
|---|---|---|
| Directly after thawing | 93.21 ± 2.63 | |
| Cryopreserved after 16 h recovery | 87.00 ± 5.87 | 25.91 ± 14.60 |
| Cryopreserved after 16 h PHA stimulation | 89.45 ± 3.85 | 40.80 ± 16.40 |
Studies that performed repair comet assay with cryopreserved blood preparations
| Type of sample | Recovery after thawing | PHA stimulation | Conditions of repair assay | Observations | References |
|---|---|---|---|---|---|
| Fresh and cryopreserved PBMCs (stored at − 70 °C) | No | Only for cryopreserved PBMCs for 2 h during repair | The alkaline comet assay was used either directly after treating with H2O2 or after Ɣ-irradiation or after 2 h repair | No difference between fresh and cryopreserved PBMCs in their response to insults or DNA repair activity | Visvardis et al. ( |
| Fresh and cryopreserved PBMCs (stored for 24 h and 2 months at − 80 °C) | No | No | The alkaline comet assay was performed either directly after treatment with H2O2 or after repair (4, 8 and 24 h) | Incubation of cryopreserved PBMCs at 37 °C after thawing caused increased DNA damage and the cryopreserved PBMCS were not able to repair | Duthie et al. ( |
| Fresh and cryopreserved PBMCs (for 1 and 3.5 h at − 80 °C) | Yes, overnight recovery for both cell preparations and then 30 min recovery after agarose embedding | No | Agarose embedded cells were irradiated (Ɣ-irradiation), and alkaline comet assay was performed at 0, 5, 15, 30 and 60 min | Cryopreserved cells showed slower DNA repair activity | Trzeciak et al. ( |
| Fresh and cryopreserved PBMCs | Yes, 24 h for both sample types | Yes, 24 h for both sample types | The APC-block NER comet assay was performed after treating with benzo[a]pyrene diol epoxide for 2 h | There was a significant correlation between the DNA repair capacity of fresh and cryopreserved PBMCs | Allione et al. ( |
| Fresh and cryopreserved PBMCs (stored for one week up to one year in liquid nitrogen) | One group of cryopreserved cells was used directly after thawing and another one after 4 h recovery | No | The alkaline comet assay was performed to analyse the repair activity directly after H2O2 treatment and after 1 h repair with or w/o APC | No difference was observed due to the freeze/thaw cycle | Odongo et al. ( |
| Fresh whole blood, cryopreserved whole blood and cryopreserved PBMCs (at least a month at − 80 °C) | Yes, 24 h for all three sample types | Yes, 24 h for all three sample types | The alkaline comet assay was performed either directly after treating with bleomycin/UVC/MMS or at three different repair times | There was no difference between fresh and cryopreserved samples except the repair of MMS induced damage, which was better in fresh samples | Valdiglesias et al. ( |